Terns Pharmaceuticals, Inc. (TERN)
Delisted
15 May 2026
NASDAQ (NGS) NASDAQ (NGS) Primary 
XSTU $
52. 95
-0.02
-0.0321%
Pre Market
$
+14.85 +28.0453% 67. 80
4.77B Market Cap
- P/E Ratio
- Div Yield
6.33M Volume
-1.33 Eps
$ 52.97
Previous Close Day Range
52.95 52.97
Year Range
2.65 53.19
Want to track TERN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Terns Pharmaceuticals, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| DB David Barlow Glazer Capital LLC | 2.3M | $121.02M | $121.02M | - | - |
| KM Kristin Mariani Janus Henderson Group PLC | 3.38M | $136.5M | $136.5M | - | - |
| KJD Kathryn J. Daniels Canada Pension Plan Investment Board | 22,600 | $913,040 | $913,040 | - | - |
| DRO Donal Reamonn O'Sullivan Brevan Howard Capital Management LP | 88,596 | $3.79M | $3.58M | -$211,694.59 | -5.58% |
 Charles Hillier Cibra Capital Ltd. | 151,440 | $7.98M | $7.98M | - | - |
2026 © Marketlog. All Rights Reserved.
